Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Aptiv $3 billion accelerated share repurchase
We advised Aptiv on the ASR transactions
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Morgan Stanley Bank $2.5 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Morgan Stanley $5.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Banco Santander $3.75 billion notes offering
We advised Banco Santander on its offering of notes
SMFG $4.5 billion senior and subordinated notes offerings
We advised SMFG on its SEC-registered offerings of TLAC notes
XP $500 million senior notes offering and concurrent tender offer
We advised XP on its Rule 144A / Regulation S unsecured notes offering and concurrent tender offer
Hertz $1 billion financing
We advised Hertz on the transactions